Suppr超能文献

卡托普利诱导饮水的机制。

Mechanism of captopril-induced drinking.

作者信息

Schiffrin E L, Genest J

出版信息

Am J Physiol. 1982 Jan;242(1):R136-40. doi: 10.1152/ajpregu.1982.242.1.R136.

Abstract

Captopril (SQ 14,225), an orally active angiotensin I-converting enzyme (ACE) inhibitor, increased drinking and produced water diuresis in rats when given orally at a dose of 100 mg.kg-1.day-1. Chronic intraperitoneal infusion of angiotensin (ANG) II or the ANG II antagonist [Sar1, Ile8]ANG II abolished this response. Intracerebroventricular (icv) captopril infused chronically reduced the dipsogenic response to oral captopril. [Sar1, Ile8]ANG II (icv) was without effect on captopril-induced drinking. These results suggest that drinking produced by chronic oral treatment of rats with captopril may be caused by the effects of the elevated ANG I concentrations achieved after blockade of ACE and stimulation of renin secretion by captopril. Systemic ANG II may reduce this response by decreasing renin secretion. Systemic [Sar1, Ile8]ANG II presumably blocks brain ANG receptors for blood-borne ANG. Since icv [Sar1, Ile8]ANG II is ineffective, the receptors for systemic and icv ANG appear to be distinct. Orally administered captopril does not diffuse into the brain.

摘要

卡托普利(SQ 14,225)是一种口服活性血管紧张素I转换酶(ACE)抑制剂,当以100mg·kg⁻¹·天⁻¹的剂量口服给予大鼠时,会增加饮水并产生水利尿。慢性腹腔注射血管紧张素(ANG)II或ANG II拮抗剂[Sar¹,Ile⁸]ANG II可消除这种反应。慢性脑室内(icv)注射卡托普利可降低对口服卡托普利的致渴反应。[Sar¹,Ile⁸]ANG II(icv)对卡托普利诱导的饮水无影响。这些结果表明,用卡托普利对大鼠进行慢性口服治疗所产生的饮水可能是由于卡托普利阻断ACE并刺激肾素分泌后所达到的升高的ANG I浓度的作用所致。全身性ANG II可能通过减少肾素分泌来降低这种反应。全身性[Sar¹,Ile⁸]ANG II大概会阻断血液中ANG的脑ANG受体。由于icv[Sar¹,Ile⁸]ANG II无效,全身性和icv ANG的受体似乎是不同的。口服给予的卡托普利不会扩散到大脑中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验